PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
285.71%
Net income growth above 1.5x CRK's 111.66%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-0.49%
Negative yoy D&A while CRK is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
170.53%
Well above CRK's 109.46% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-16200.00%
Both reduce yoy usage, with CRK at -132.44%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-16200.00%
Both reduce yoy usage, with CRK at -103.72%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
-79.06%
Both negative yoy, with CRK at -114.79%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-31.12%
Both yoy CFO lines are negative, with CRK at -18.42%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-18.42%
Both yoy lines negative, with CRK at -21.07%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
130.90%
Acquisition growth of 130.90% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3142.11%
Both yoy lines negative, with CRK at -60.45%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
18.54%
We have mild expansions while CRK is negative at -174.50%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.